About US
Contact us
-
Bayer Healthcare posts big growth in Asia PacificBayer Healthcare is on a roll in Asia. The German company toted up a 9.4% increase in Asia Pacific sales last year, for a regional total of 3.6 billion euros, or $4.8 billion. And it has even bigger a2012/3/12
-
Bayer, Novartis circle Pfizer's animal health unitPfizer's ($PFE) animal health unit may not be to Sanofi's ($SNY)taste, but Bayer and Novartis ($NVS)appear to have an appetite for it. Sources close to the process tell Reuters that Bayer is shopping2012/3/9
-
SFDA specifies relevant requirements for the registration of medical devices with adjusted management classificationIn order to further standardize the registration of medical devices, and in accordance with relevant regulations, the State Food and Drug Administration (SFDA) recently issued a notice to specify the2012/3/9
-
Roche can shop around if Illumina bid fails, Humer saysPlay hard to get all you want, Illumina. Roche Chairman Franz Humer says there are plenty of other fish in the gene-sequencing sea. "Illumina is not the only gene-sequencing company, and there are oth2012/3/8
-
SFDA specifies requirements for the supervision of decorative plano colored contact lensesThe State Food and Drug Administration (SFDA) recently issued a notice on the supervision of decorative plano colored contact lenses. According to the notice, the registration application of decorat2012/3/8
-
Copycat Lipitor hits in 4 EU countriesGeneric Lipitor is on the ground in four more markets. Ranbaxy Laboratories launched its version of the Pfizer ($PFE) cholesterol blockbuster in Italy, Sweden and the Netherlands, while its German sub2012/3/7
-
HHS: Misbehaving drugmakers could lose patent rightsBig Pharma has paid big money to resolve big government investigations over the past 10 years--$8 billion, in fact, according to USA Today's calculations. That's no secret to anyone who follows the in2012/3/7
-
Chinese official chides hospitals for high drug pricesChinese healthcare reforms can't succeed if hospitals keep pushing up drug prices, the country's health minister said over the weekend. Quoting Xinhua, Reuters reportsthat hospitals derive a big chunk2012/3/6
-
EC drops antitrust probe aimed at GSKEuropean antitrust police are dropping another pharmaceutical probe. This time, the European Commission's competition regulator has stopped an investigation into GlaxoSmithKline ($GSK), Reuters report2012/3/6
-
Chinese pharmas feel the squeeze of healthcare reformEven though China is set to become the second-largest drug market by 2020, all is not rosy for its native drugmakers. Agovernment push todrive down costs forhealthcare end users is pressuringpharma co2012/3/5